Abstract 3219: Arid1a directs lineage specification in mammary epithelial cells

Abstract Epigenetic regulation is essential for mammary gland development, yet the specific chromatin remodelers that govern mammary epithelial cell fate remain poorly defined. Mutations in SWI/SNF chromatin remodeling complex subunits occur in more than 20% of human cancers, with ARID1A being the most frequently altered. In breast cancer, ARID1A loss of function mutations are enriched in metastatic estrogen receptor-positive (ER+) disease and associated with endocrine therapy resistance. To define the developmental role of Arid1a in vivo, we generated mice with mammary epithelium specific Arid1a deletion. These animals displayed disrupted ductal branching and aberrant terminal end bud formation. Mammary organoids derived from Arid1a deficient tissue further revealed abnormal cystic morphology and impaired differentiation. To dissect the molecular consequences of Arid1a loss, we performed single cell multiomic profiling that combine single nucleus RNA and chromatin accessibility sequencing from the same cells, together with H3K27ac and BRG1 CUT&RUN-seq. Arid1a loss caused a collapse of normal mammary epithelial lineage architecture, with single cell analyses showing failure to maintain basal, luminal progenitor, and alveolar identities. Instead, Arid1a deficient cells were restricted to an undifferentiated luminal hormonal like state characterized by reduced estrogen receptor signaling competence. Chromatin profiling revealed profound remodeling, including decreased accessibility and impaired SWI/SNF targeting at lineage defining transcription factors (TF) such as Foxa1, Gata3, and Sox9. A CRISPR/Cas9 pooled loss of function screen identified Foxa1 and Meis1 as essential regulators whose deletion recapitulated the Arid1a null phenotype, positioning them as downstream effectors required for mammary cell fate specification. Notably, Meis1 emerged as a previously unrecognized regulator of luminal hormonal identity. Our work provides a framework for understanding how Arid1a rewires the chromatin landscape and transcriptional network in normal mammary development. By identifying lineage specific TF motifs and critical regulators like Meis1, we identify new opportunities for targeted therapeutic intervention. Citation Format: Erik Ladewig, Amaia Arruabarrena-Aristorena, Estelle Deby, Srushti Kittane, Fresia Pareja, Ryan Blawski, Yangzhenyu Gao, Laura Baldino, Vito Rebecca, Emiliano Cocco, Hongkai Ji, Pau Castel, Christina Leslie, Wouter Karthaus, Eneda Toska. Arid1a directs lineage specification in mammary epithelial cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3219.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-3219
Primary Topic
Chromatin Remodeling and Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 3219: Arid1a directs lineage specification in mammary epithelial cells

Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Fresia Pareja, Srushti Kittane et al.
Cancer Research
Chromatin Remodeling and Cancer
article

Abstract 3219: Arid1a directs lineage specification in mammary epithelial cells

Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Fresia Pareja, Srushti Kittane, Wouter R. Karthaus, Hongkai Ji, Erik Ladewig, Laura Baldino, Emiliano Cocco, Ryan Blawski, Eneda Toska, Pau Castel, V. Rebecca, Estelle Deby, Christina Leslie
article en

Abstract

Abstract Epigenetic regulation is essential for mammary gland development, yet the specific chromatin remodelers that govern mammary epithelial cell fate remain poorly defined. Mutations in SWI/SNF chromatin remodeling complex subunits occur in more than 20% of human cancers, with ARID1A being the most frequently altered. In breast cancer, ARID1A loss of function mutations are enriched in metastatic estrogen receptor-positive (ER+) disease and associated with endocrine therapy resistance. To define the developmental role of Arid1a in vivo, we generated mice with mammary epithelium specific Arid1a deletion. These animals displayed disrupted ductal branching and aberrant terminal end bud formation. Mammary organoids derived from Arid1a deficient tissue further revealed abnormal cystic morphology and impaired differentiation. To dissect the molecular consequences of Arid1a loss, we performed single cell multiomic profiling that combine single nucleus RNA and chromatin accessibility sequencing from the same cells, together with H3K27ac and BRG1 CUT&RUN-seq. Arid1a loss caused a collapse of normal mammary epithelial lineage architecture, with single cell analyses showing failure to maintain basal, luminal progenitor, and alveolar identities. Instead, Arid1a deficient cells were restricted to an undifferentiated luminal hormonal like state characterized by reduced estrogen receptor signaling competence. Chromatin profiling revealed profound remodeling, including decreased accessibility and impaired SWI/SNF targeting at lineage defining transcription factors (TF) such as Foxa1, Gata3, and Sox9. A CRISPR/Cas9 pooled loss of function screen identified Foxa1 and Meis1 as essential regulators whose deletion recapitulated the Arid1a null phenotype, positioning them as downstream effectors required for mammary cell fate specification. Notably, Meis1 emerged as a previously unrecognized regulator of luminal hormonal identity. Our work provides a framework for understanding how Arid1a rewires the chromatin landscape and transcriptional network in normal mammary development. By identifying lineage specific TF motifs and critical regulators like Meis1, we identify new opportunities for targeted therapeutic intervention. Citation Format: Erik Ladewig, Amaia Arruabarrena-Aristorena, Estelle Deby, Srushti Kittane, Fresia Pareja, Ryan Blawski, Yangzhenyu Gao, Laura Baldino, Vito Rebecca, Emiliano Cocco, Hongkai Ji, Pau Castel, Christina Leslie, Wouter Karthaus, Eneda Toska. Arid1a directs lineage specification in mammary epithelial cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3219.

Cancer ResearchVol. 86(7_Supplement)
Memorial Sloan Kettering Cancer Center (US), Johns Hopkins University (US), University of Miami (US), University of the Basque Country (ES), University of California, San Francisco (US), Kettering University (US), École Polytechnique Fédérale de Lausanne (CH), University of Baltimore (US)
Good health and well-being
Openalex Percentile: Top 6%
Chromatin Remodeling and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.